APP and lung adenocarcinoma: Already in 1998, Nakano et al. observed significantly elevated serum levels of some acute phase response proteins (APP) and cytokines—namely fibrinogen, IL-6, alpha1-acid glycoprotein and CRP levels—in MPM patients compared to patients with adenocarcinoma of the lung.